Skip to main content

Table 3 Correlations between LBP and sCD14 and metabolic and inflammatory variables in the total population and in subjects with MetS

From: Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study

 

In the total population (n = 482)

In subjects with MetS (n = 182)

LBP

sCD14

LBP

sCD14

r

p

r

p

r

p

r

p

BMI

0.05

0.33

− 0.04

0.34

− 0.06

0.04

0.03

0.70

Waist circumference

0.11

0.02

− 0.01

0.89

0.01

0.95

0.13

0.10

Triglycerides

− 0.03

0.56

0.01

0.84

− 0.01

0.86

0.15

0.04

HDL cholesterol

− 0.04

0.37

0.02

0.62

− 0.08

0.31

− 0.11

0.15

Systolic blood pressure

0.01

0.78

0.01

0.87

− 0.05

0.51

0.02

0.80

Diastolic blood pressure

0.04

0.36

0.12

0.01

− 0.02

0.79

0.07

0.37

Fasting glucose

0.001

0.96

0.01

0.80

− 0.01

0.93

0.10

0.18

Insulin

0.10

0.04

0.02

0.74

0.13

0.08

0.02

0.75

HOMA

0.08

0.11

0.03

0.59

0.10

0.18

0.07

0.39

TG/HDL ratio

− 0.01

0.82

0.01

0.86

0.02

0.80

0.15

0.04

CRP

0.22

< 0.001

0.14

0.003

0.17

0.03

0.09

0.23

IL-6

0.23

< 0.001

0.16

< 0.001

0.2

0.001

0.17

0.02

IL-18

0.15

0.001

0.18

< 0.001

0.17

0.02

0.26

< 0.001

TNFα

0.15

0.001

0.10

0.04

0.24

0.001

0.06

0.39

  1. For abbreviations, see text. Italic text indicates p-values below < 0.05. Subjects with MetS, refers to subjects with 3 out of 5 or more MetS criteria according to the NCEP ATP III definition